Fox Run Management, L.L.C. Charles River Laboratories International, Inc. Transaction History

Fox Run Management, L.L.C.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$191.89 - $259.92 $828,964 - $1.12 Million	4,320 New	4,320 $871,000
Q2 2022 Aug 12, 2022	BUY	$204.13 - $302.4 $520,327 - $770,817	2,549 New	2,549 $545,000
Q3 2020 Oct 29, 2020	SELL	$175.56 - $226.45 $202,596 - $261,323	-1,154 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$118.84 - $189.72 $137,141 - $218,936	1,154 New	1,154 $201,000
Q1 2019 Oct 17, 2019	SELL	$104.82 - $146.73 $745,899 - $1.04 Million	-7,116 Closed	0 $0
Q4 2018 Jan 15, 2019	BUY	$105.09 - $137.23 $747,820 - $976,528	7,116 New	7,116 $805,000
Q2 2018 Jul 17, 2018	SELL	$102.37 - $117.25 $681,784 - $780,885	-6,660 Closed	0 $0
Q1 2018 Apr 17, 2018	BUY	$98.19 - $115.2 $653,945 - $767,232	6,660 New	6,660 $711,000
Q4 2017 Jan 18, 2018	SELL	$100.43 - $118.09 $441,892 - $519,596	-4,400 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$96.72 - $109.26 $425,568 - $480,744	4,400	4,400 $475,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.